glp 1 compound fda says that the GLP-1 shortage is over Compounded GLP-1s: Why doctors worry

Kidney Protection and Brain Health A trial found semaglutide reduced kidney events by 24% in people with type 2 diabetes and chronic kidney disease using a lower dose, not the maximum. GLP-1s also strengthen the blood-brain barrier and enhance neuron survival, with early data hinting at benefits for cognitive decline and Alzheimer's disease. Systemic Anti-Inflammatory Effects GLP-1s reduce systemic inflammation throughout the body. This benefit doesn't get talked about much, though inflammation drives almost every chronic disease

Vitamin B6 is also effective to relieve nausea and vomiting

However, the drug was subsequently overtaken by Pfizers Lipitor (FDA-approved in 1996), which generated ~$100B in sales from 1992 to 2017

This is both good and bad

What are the dosage forms and doses of semaglutide

Biology 11:553